TGTX Tg Therapeutics RESULTS: Q2, Q2 Operating Income $21.674M, Q2 Net Income $7.781M, Q2 product REV $235.794M
TGTX Tg Therapeutics RESULTS: Q2, Q2 Operating Income $21.674M, Q2 Net Income $7.781M, Q2 product REV $235.794M
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.